
Stanford Biosciences Private Limited
About Stanford Biosciences Private Limited
Data last updated:
Stanford Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2013PTC252562. Its GSTIN is 07AATCS1320F1ZG (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rachna Duggal and Nihit Duggal.
Its last annual general meeting (AGM) was held on 02 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 181 1st Floor Naraina Industrial Area Phase – 1, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.78 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹8.84 Lakh (net margin 5%) and EBITDA of ₹16.7 Lakh (EBITDA margin 9.4%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹65 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Stanford Biosciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 181 1st Floor Naraina Industrial Area Phase – 1, New Delhi, Delhi, India – 110028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Stanford Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stanford Biosciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Stanford Biosciences Private Limited, buy the company report.
Financials of Stanford Biosciences Private Limited
FY 2025 filings availableStanford Biosciences Private Limited reported revenue of ₹1.78 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 4% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stanford Biosciences Private Limited, buy the company report.
Board of directors of Stanford Biosciences Private Limited
Stanford Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachna Duggal | Director | 23 May 2013 | 13 Years 5 Months | Current |
| Nihit Duggal | Director | 23 May 2013 | 13 Years 5 Months | Current |
Auditor
Stanford Biosciences Private Limited is audited by BUBNA & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BUBNA & ASSOCIATES | FY 2016 | 021138N |
Shareholding
The shareholding of Stanford Biosciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Stanford Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2025 | 101179440 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 03 Nov 2015 | 10604556 | Punjab National Bank | ₹35 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Stanford Biosciences Private Limited has 1 court case on record: 1 filed by Stanford Biosciences. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Stanford Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stanford Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stanford Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AATCS1320F1ZG | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stanford Biosciences Private Limited, buy the company report.
Recent activity
Stanford Biosciences Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Nihit Duggal was appointed as Director on 23 May 2013.
Frequently asked questions
Stanford Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 May 2013 (13+ years old) and is registered under CIN U74900DL2013PTC252562.
Stanford Biosciences has 2 current directors:
- Rachna Duggal - Director
- Nihit Duggal - Director
The latest financial statements of Stanford Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 02 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stanford Biosciences is 07AATCS1320F1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Stanford Biosciences is U74900DL2013PTC252562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanford Biosciences has 1 court case on record: 1 filed by the company. 1 is pending.
Stanford Biosciences was incorporated on 23 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Nihit Duggal was appointed as Director on 23 May 2013. Rachna Duggal was appointed as Director on 23 May 2013.
The registered office of Stanford Biosciences is at C – 181 1st Floor Naraina Industrial Area Phase – 1, New Delhi, Delhi, India – 110028.
Stanford Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

